Denmark· DK-28105934017
Combiflure
A fluorescein, kombinationen product containing fluoresceinnatrium, oxybuprocainhydrochlorid, registered in Denmark by Santen Oy. The same ATC class is registered in 7 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Fluorescein, kombinationen is registered in 7 of 19 countries.
Countries holding a registration under ATC S01JA51 (fluorescein, kombinationen), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 4 of them publish a price we can compare per daily dose
Fluorescein, kombinationen · ATC S01JA51
7 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Switzerlandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Fluoresceinnatrium, Oxybuprocainhydrochlorid
- Manufacturer
- Santen Oy
- Country
- Denmark (DK)
- ATC code
- S01JA51
- ATC class
- Fluorescein, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105934017
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under S01JA51
Fluorescein, kombinationen, as other registers publish it.
- NorwayCombiflureSanten Oy
- BelgiumCombiflure 1.25 mg/ml - 3 mg/mlSanten
- SwitzerlandFluoresceine Oxybuprocaine SDU Faure, AugentropfenOmniVision AG
- SwitzerlandFluoresceine Oxybuprocaine SDU Faure, AugentropfenOmniVision AG
- FinlandFluressPfizer Health Ab
- NorwayLidocaine + Fluorescein MinimsBausch & Lomb GmbH
- IrelandMinims Lidocaine Hydrochloride 4% w/v & Fluorescein Sodium 0.25% w/v Eye Drops, solutionBausch + Lomb Ireland Limited
- NetherlandsMinims Lidocaine-Fluoresceine, oogdruppels, oplossingBausch + Lomb Ireland Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/54571120-758a-49f9-b95b-906759eb09c2 GET /v1/drugs/54571120-758a-49f9-b95b-906759eb09c2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "øjendråber, opløsning",
"source": "dkma",
"strength": "1,25+3 mg/ml",
"auth_role": "CMS",
"dk_drugid": "28105934017",
"substance": "Fluoresceinnatrium, Oxybuprocainhydrochlorid",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": true,
"registration_date_serial": "43164"
}See everything about fluorescein, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.